
Sensient (SXT) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
392.3M
Gross Profit
131.8M
33.59%
Operating Income
53.5M
13.64%
Net Income
34.5M
8.78%
EPS (Diluted)
$0.81
Balance Sheet Metrics
Total Assets
2.1B
Total Liabilities
997.6M
Shareholders Equity
1.1B
Debt to Equity
0.91
Cash Flow Metrics
Operating Cash Flow
20.7M
Free Cash Flow
-25.8M
Revenue & Profitability Trend
Sensient Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 1.6B | 1.5B | 1.4B | 1.4B | 1.3B |
Cost of Goods Sold | 1.1B | 996.2M | 947.9M | 925.6M | 908.3M |
Gross Profit | 507.1M | 460.3M | 489.1M | 454.7M | 423.7M |
Gross Margin % | 32.6% | 31.6% | 34.0% | 32.9% | 31.8% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 315.5M | 305.3M | 292.4M | 284.6M | 271.1M |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 315.5M | 305.3M | 292.4M | 284.6M | 271.1M |
Operating Income | 191.6M | 155.0M | 196.8M | 170.0M | 152.7M |
Operating Margin % | 12.3% | 10.6% | 13.7% | 12.3% | 11.5% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 28.8M | 25.2M | 14.5M | 12.5M | 14.8M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 162.8M | 129.9M | 182.2M | 157.5M | 137.8M |
Income Tax | 38.1M | 36.5M | 41.3M | 38.7M | 28.4M |
Effective Tax Rate % | 23.4% | 28.1% | 22.7% | 24.6% | 20.6% |
Net Income | 124.7M | 93.4M | 140.9M | 118.7M | 109.5M |
Net Margin % | 8.0% | 6.4% | 9.8% | 8.6% | 8.2% |
Key Metrics | |||||
EBITDA | 251.9M | 212.8M | 249.2M | 222.1M | 202.3M |
EPS (Basic) | $2.96 | $2.22 | $3.36 | $2.82 | $2.59 |
EPS (Diluted) | $2.94 | $2.21 | $3.34 | $2.81 | $2.59 |
Basic Shares Outstanding | 42145000 | 42027000 | 41888000 | 42077000 | 42301000 |
Diluted Shares Outstanding | 42145000 | 42027000 | 41888000 | 42077000 | 42301000 |
Income Statement Trend
Sensient Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 26.6M | 28.9M | 20.9M | 25.7M | 24.8M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 290.1M | 272.2M | 302.1M | 261.1M | 234.1M |
Inventory | 600.3M | 598.4M | 564.1M | 411.6M | 381.3M |
Other Current Assets | 44.9M | 37.1M | 47.6M | 42.7M | - |
Total Current Assets | 961.9M | 936.6M | 934.8M | 741.2M | 741.6M |
Non-Current Assets | |||||
Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 |
Goodwill | 835.4M | 860.2M | 850.0M | 855.0M | 857.5M |
Intangible Assets | 11.9M | 12.1M | 18.6M | 15.0M | 10.9M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 146.7M | 136.4M | 129.3M | 122.9M | 119.6M |
Total Non-Current Assets | 1.1B | 1.1B | 1.0B | 1.0B | 999.3M |
Total Assets | 2.0B | 2.0B | 2.0B | 1.7B | 1.7B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 139.1M | 131.1M | 142.4M | 125.5M | 107.3M |
Short-term Debt | 19.8M | 13.5M | 20.4M | 8.5M | 9.2M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | 17.3M |
Total Current Liabilities | 270.6M | 236.3M | 272.2M | 232.3M | 216.0M |
Non-Current Liabilities | |||||
Long-term Debt | 613.5M | 645.1M | 630.3M | 503.0M | 518.0M |
Deferred Tax Liabilities | 14.6M | 14.3M | 16.0M | 14.3M | 13.4M |
Other Non-Current Liabilities | 39.5M | 37.8M | 37.2M | 28.8M | 30.2M |
Total Non-Current Liabilities | 692.2M | 724.9M | 709.9M | 574.8M | 590.6M |
Total Liabilities | 962.8M | 961.2M | 982.0M | 807.1M | 806.5M |
Equity | |||||
Common Stock | 5.4M | 5.4M | 5.4M | 5.4M | 5.4M |
Retained Earnings | 1.8B | 1.7B | 1.7B | 1.6B | 1.6B |
Treasury Stock | 617.2M | 622.8M | 631.9M | 634.4M | 593.5M |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 1.1B | 1.1B | 999.6M | 938.4M | 934.3M |
Key Metrics | |||||
Total Debt | 633.4M | 658.5M | 650.7M | 511.5M | 527.3M |
Working Capital | 691.2M | 700.3M | 662.6M | 508.8M | 525.6M |
Balance Sheet Composition
Sensient Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 124.7M | 93.4M | 140.9M | 118.7M | 109.5M |
Depreciation & Amortization | 60.3M | 57.8M | 52.5M | 52.1M | 49.6M |
Stock-Based Compensation | 10.1M | 8.9M | 16.1M | 9.6M | 5.6M |
Working Capital Changes | -37.7M | 3.3M | -187.0M | -44.7M | 53.8M |
Operating Cash Flow | 140.2M | 182.4M | 11.5M | 129.6M | 216.8M |
Investing Activities | |||||
Capital Expenditures | -59.2M | -87.9M | -79.3M | -60.8M | -52.2M |
Acquisitions | 0 | -1.6M | -20.2M | 23.9M | 12.6M |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -59.2M | -87.6M | -98.4M | -35.6M | -33.4M |
Financing Activities | |||||
Share Repurchases | - | 0 | 0 | -42.5M | 0 |
Dividends Paid | -69.4M | -69.2M | -68.9M | -66.7M | -66.1M |
Debt Issuance | 159.3M | 351.7M | 328.6M | 112.2M | 36.7M |
Debt Repayment | -167.1M | -355.2M | -171.4M | -110.2M | -154.3M |
Financing Cash Flow | -81.5M | -82.0M | 414.8M | 4.4M | -184.2M |
Free Cash Flow | 97.9M | 81.8M | -67.3M | 84.4M | 166.6M |
Net Change in Cash | -575.0K | 12.8M | 327.8M | 98.5M | -814.0K |
Cash Flow Trend
Sensient Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
36.05
Forward P/E
33.22
Price to Book
4.17
Price to Sales
3.08
PEG Ratio
33.22
Profitability Ratios
Profit Margin
8.56%
Operating Margin
14.74%
Return on Equity
12.18%
Return on Assets
6.30%
Financial Health
Current Ratio
4.24
Debt to Equity
63.64
Beta
0.57
Per Share Data
EPS (TTM)
$3.17
Book Value per Share
$27.39
Revenue per Share
$37.34
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
sxt | 4.9B | 36.05 | 4.17 | 12.18% | 8.56% | 63.64 |
Linde plc | 222.6B | 34.37 | 5.86 | 17.01% | 20.02% | 60.56 |
Sherwin-Williams | 86.3B | 34.25 | 19.53 | 62.43% | 11.03% | 308.57 |
Albemarle | 9.9B | 33.52 | 1.26 | -9.99% | -22.39% | 35.76 |
Eastman Chemical | 7.0B | 8.57 | 1.20 | 14.39% | 8.96% | 90.60 |
NewMarket | 6.7B | 14.05 | 4.13 | 33.74% | 17.28% | 56.98 |
Financial data is updated regularly. All figures are in the company's reporting currency.